NI
CHRS icon

Numeric Investors’s Coherus Oncology CHRS Stock Holding History

Numeric Investors’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-54,700
Closed -$1.47M – 1049
2016
Q3 		$1.47M Buy
+54,700
New +$1.49M 0.01% 529
2016
Q1 		– Sell
-81,118
Closed -$1.86M – 999
2015
Q4 		$1.86M Sell
81,118
-121,148
-60% -$3.12M 0.02% 454
2015
Q3 		$4.05M Buy
+202,266
New +$6.15M 0.05% 277

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors's CHRS Position: Q4 2016 in Review

Numeric Investors sold out of Coherus Oncology (CHRS) in Q4 2016, closing a stake of 54,700 shares — an estimated $1.47M sold.

Numeric Investors first reported a position in CHRS in Q3 2015 and held it in 3 quarters. The position peaked at $4.05M in Q3 2015. 122 funds tracked by Wall St. Rank hold CHRS as of Q4 2016.

  • Numeric Investors reported no remaining Coherus Oncology position as of Q4 2016 after selling out during the quarter.
  • Numeric Investors sold 54,700 Coherus Oncology shares in Q4 2016, an estimated $1.47M.
  • Numeric Investors first reported a position in Coherus Oncology in Q3 2015 and held it in 3 quarters.
  • Numeric Investors's Coherus Oncology position peaked at $4.05M in Q3 2015.
  • 122 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2016.

Based on Numeric Investors's 13F filing for Q4 2016, filed 13 Feb 2017.